CLX vs PG: Which Stock Is the Better Buy?
Clorox Company (The) and Procter & Gamble Company (The) side by side — fundamentals from SEC filings, refreshed nightly. Sector: Consumer Defensive.
AI verdict — CLX vs PG, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Clorox Company (The) (CLX) | Procter & Gamble Company (The) (PG) | |
|---|---|---|
| Market cap | — | — |
| Revenue (latest FY) | $7.10B | $87.03B |
| Net income (latest FY) | $810.00M | $16.05B |
| Revenue growth (5y CAGR) | 1.1% | 2.7% |
| Net margin | 11.4% | 18.4% |
| Return on equity | 252.3% | — |
| P/E ratio | 15.5 | 21.8 |
| Dividend yield | 5.2% | 3.0% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | — |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full CLX vs PG breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open CLX's full financials → Open PG's full financials →Frequently asked questions
Which is bigger, CLX or PG?
Market capitalization data is not available for both companies.
Which grows faster, CLX or PG?
Over the last five fiscal years, Procter & Gamble Company (The) grew revenue faster — 2.7%/yr versus 1.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.